Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-β1 enhanced IL-18 expression in human renal proximal tubular epithelial cells

Diabetes Research and Clinical Practice

Volumn 83, Issue 2, 2009, Pages 190-199

  Miyauchi, Kazunari ^a   Takiyama, Yumi ^a   Honjyo, Jun ^a   Tateno, Masatoshi ^a   Haneda, Masakazu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Diabetic Nephropathy; IL 18; TGF 1

Indexed keywords

INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 18 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; WESTERN BLOTTING;

AGED; CASPASE 1; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; KIDNEY TUBULES, PROXIMAL; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 58249104254     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.11.018     Document Type: Article

References (44)

1. Scherijvers B.F., De Vriese A.S., and Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr. Rev. 25 (2004) 971-1010
2. Navarro-Gonzalez J.F., and Mora-Fernandez C. The role of inflammatory cytokine in diabetic nephropathy. J. Am. Soc. Nephrol. 19 (2008) 433-442
3. Reeves W.B., and Andreoli T.E. Transforming growth factor-β contributes to progressive diabetic nephropathy. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7667-7669
4. Zhu Y., Usui H.K., and Sharma K. Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Semin. Nephrol. 27 (2007) 153-160
5. Yamamoto T., Nakamura T., Noble N.A., Ruoslahti E., and Border W.A. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1814-1818
6. Sharma K., Ziyadeh F.N., Alzahabi B., McGowan T.A., Kapoor S., Kumik B.R.C., et al. Increased renal production of transforming growth factor-beta 1 in patients with type II diabetes. Diabetes 46 (1997) 854-859
7. 1, its type II receptor, and activation of the smad signaling pathway in the db/db mice. Am. J. Pathol. 158 (2001) 1653-1663
8. McGowan T.A., Dunn S.R., Falkner B., and Sharma K. Stimulation of urinary TGF-beta and isoprostanes in response to hyperglycemia in humans. Clin. J. Am. Soc. Nephrol. 1 (2006) 263-268
9. Sato H., Iwano M., Akai Y., Kurioka H., Kubo A., Yamaguchi T., et al. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am. J. Nephrol. 18 (1998) 490-494
10. 1 generation and monocyte binding. Am. J. Pathol. 165 (2004) 763-773
11. 1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am. J. Physiol. Renal. Physiol. 290 (2006) F703-709
12. Liang D., Liu H.F., Yao C.W., Liu H.Y., Huang-Fu C.M., Chen X.W., et al. Effects of interleukin 18 on injury and activation of human proximal tubular epithelial cells. Nephrology 12 (2007) 53-61
13. Nakamura A., Shikata K., Hiramatsu M., Nakatou T., Kitamura T., Wada J., et al. Serum interleukn-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 28 (2005) 2890-2895
14. Moriwaki Y., Yamamoto T., Shibutani Y., Aoiki E., Tsutsumi Z., Takahashi S., et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52 (2003) 605-608
15. Mahmoud R.A., el-EZZ S.A., and Hegazy A.S. Increased serum levels of IL-18 in patients with diabetic nephropathy. Ital. J. Biochem. 53 (2004) 73-81
16. Araki S., Haneda M., Koya D., Sugimoto T., Isshiki K., Chin-Kanasaki M., et al. Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study. Diabetologia 50 (2007) 867-873
17. Ushio S., Namba M., Okura T., Hattori K., Nukada Y., Akita K., et al. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immnol. 156 (1996) 4274-4279
18. Sassy-Prigent C., Heudes D., Mandet C., Belair M.F., Michel O., Perdereau B., et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49 (2000) 466-475
19. Navarro J.F., Milena F.J., Mora C., Leon C., and Garcia J. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifyline administration. Am. J. Nephrol. 26 (2006) 562-570
20. Nikolic-Paterson D.J., Main I.W., Tesch G.H., Lan H.Y., and Atkins R.C. Interleukin-1 in renal fibrosis. Kidney Int. Suppl. 54 (1996) S88-S90
21. Vesey D.A., Cheung C.W., Cuttle L., Endre Z.A., Gobe G., and Johnson D.W. Interleukin-1β induces human proximal tubule cell injury, α-smooth muscle actin expression and fibronectin production. Kidney Int. 62 (2002) 31-40
22. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Role of oxidative stress. Circulation 106 (2002) 2067-2072
23. Aso Y., Okumura K., Takebayashi K., Wakabayashi S., and Inukai T. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care 26 (2003) 2622-2627
24. Fischer C.P., Perstrup L.B., Berntsen A., Eskildsen P., and Pedersen B.K. Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin. Immunol. 117 (2005) 152-160
25. Thorand B., Kolb H., Baumert J., Koenig W., Chambless L., Meisinger C., et al. Elevated levels of Interleukin-18 predict the development of type 2 diabetes. Results from the MONICA/KORA Augsburg study, 1984-2002. Diabetes 54 (2005) 2932-2938
26. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19 (2001) 423-474
27. Lebel-Binay S., Berger A., Zinzindohoue F., Cugnenc P., Thiounn N., Fridman W.H., et al. Interleukin-18: biological properties and clinical implications. Eur. Cytokine Netw. 11 (2000) 15-26
28. Fukushima T., Nagashima Y., Nakatani Y., Nakamura N., Fukasawa K., Satomi Y., et al. Chromophobe renal cell carcinoma: a report of two cases. Pathol. Int. 44 (1994) 401-406
29. 1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 293 (2007) L790-799
30. lpr mice. J. Immunol. 173 (2004) 5312-5318
31. Gutcher I., Urich E., Wolter K., Prinz M., and Becher B. Interleukin 18-independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation. Nat. Immunol. 7 (2006) 946-953
32. Mezzano S., Droguett A., Burgos M.E., Ardiles L.G., Flores C.A., Aros C.A., et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int. Suppl. 84 (2003) S64-70
33. Choi M.E. Mechanism of transforming growth factor-beta 1 signaling. Kidney Int. Suppl. 77 (2000) S53-58
34. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 425 (2003) 577-584
35. Calvani N., Richards H.B., Tucci M., Pannarale G., and Silvestris F. Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Clin. Exp. Immunol. 138 (2004) 171-178
36. Coca S.G., Yalavarthy R., Concato J., and Parikh C.R. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 73 (2008) 1008-1016
37. Hewins P., Morgan M.D., Holden N., Neil D., Williams J.M., Savage C.O., et al. IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int. 69 (2006) 605-615
38. lpr mice with autoimmune lupus nephritis. Arthritis Rheum. 46 (2002) 3083-3095
39. Striz I., Eliska K., Honsova E., Lacha J., Petrickova K., Jaresova M., et al. Interleukin-18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol. Lett. 99 (2005) 30-35
40. Melnikov V.Y., Faubel S., Siegmund B., Lucia M.S., Ljubanovic D., and Edelstein C.L. Neutrophil-independent mechanisms of caspase-1-and IL-18-mediated ischemic acute tubular necrosis in mice. J. Clin. Invest. 110 (2002) 8031-1091
41. Bohle A., Muller G.A., Wehrmann M., Mackensen-Haen S., and Xiao J.C. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int. Suppl. 54 (1996) S2-9
42. Rubin-Kelly V.E., and Jevnikar A.M. Antigen presentation by renal tubular epithelial cells. J. Am. Soc. Nehprol. 2 (1991) 13-26
43. Segerer S., Nelson P.J., and Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathphysiologic and therapeutic studies. J. Am. Soc. Nephrol. 11 (2000) 152-176
44. Haneda M., Araki S., Togawa M., Sugimoto T., Isono M., and Kikkawa R. Activation of mitogen-activated protein kinase cascade in diabetic glomeruli and mesangial cells cultured under high glucose conditions. Kidney Int. Suppl. 60 (1997) S66-69